Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: Anti-apoptosis by alpha-2-adrenergic receptor activation

Survey of Ophthalmology

Volumn 48, Issue 2 SUPPL. 1, 2003, Pages

  Tatton, William ^a   Chen, David ^a   Chalmers Redman, Ruth ^a   Wheeler, Larry ^c   Nixon, Ralph ^b   Tatton, Nadine ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c ALLERGAN INC   (United States)

Author keywords

Alpha 2 receptor agonist; Alzheimer's disease; Anti apoptosis signaling; Apoptosis; Glaucoma; Locus ceruleus; Noradrenaline

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMYLOID BETA PROTEIN; NORADRENALIN; PROTEIN KINASE B; TAU PROTEIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; APOPTOSIS; CELL LOSS; DRUG EFFECT; GLAUCOMA; HUMAN; LOCUS CERULEUS; MITOCHONDRIAL MEMBRANE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NERVE ENDING; NERVE FIBER; NEUROPROTECTION; NORADRENERGIC NERVE; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; SIGNAL TRANSDUCTION; CELL PROTECTION; METABOLISM;

ADRENERGIC ALPHA-AGONISTS; ALZHEIMER DISEASE; APOPTOSIS; CYTOPROTECTION; GLAUCOMA; HUMANS; NEUROPROTECTIVE AGENTS; RECEPTORS, ADRENERGIC, ALPHA-2; RETINAL GANGLION CELLS;

EID: 1242289391     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(03)00005-5     Document Type: Article

References (216)

1. Adamec E, Vonsattel JP, Nixon RA: DNA strand breaks in Alzheimer's disease. Brain Res 849:67-77, 1999
2. Ahmed FA, Hegazy K, Chaudhary P, Sharma SC: Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure. Brain Res 91 3:133-9, 2001
3. Anderson AJ, Su JH, Cotman CW: DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 16:1710-9, 1996
4. Annaert W, De Strooper B: A cell biological perspective on Alzheimer's disease. Annu Rev Cell Dev Biol 18:25-51, 2002
5. Arai H, Kosaka K, Iizuka R: Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J Neurochem 43:388-93, 1984
6. Avila J, Lim F, Moreno F, et al: Tau function and dysfunction in neurons: its role in neurodegenerative disorders. Mol Neurobiol 25:213-31, 2002
7. Bamberger ME, Landreth GE: Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist 8:276-83, 2002
8. Baptiste DC, Hartwick AT, Jollimore CA, et al: Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina. Invest Ophthalmol Vis Sci 43:2666-76, 2002
9. Basanez G, Nechushtan A, Drozhinin O, et al: Bax, but not Bcl-x(L), decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc Natl Acad Sci USA 96:5492
10. Proceedings of the National Academy of Sciences of the United States of America 7, 1999
11. Bayer AU, Ferrari F, Erb C: High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 47:165-8, 2002
12. Bayer AU, Keller ON, Ferrari F, Maag KP: Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 133:135-7, 2002
13. Bazan NG, Palacios-Pelaez R, Lukiw WJ: Hypoxia signaling to genes: significance in Alzheimer's disease. Mol Neurobiol 26:283-98, 2002
14. Blanks JC, Torigoe Y, Hinton DR, Blanks RH: Retinal degeneration in the macula of patients with Alzheimer's disease. Ann NY Acad Sci 640:44-6, 1991
15. Bommakanti RK, Vinayak S, Simonds WF: Dual regulation of Akt/protein kinase B by heterotrimeric G protein subunits. J Biol Chem 275:38870-6, 2000
16. Bondareff W, Mountjoy CQ, Roth M: Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Lancet 1:783-4, 1981
17. Bondareff W, Mountjoy CQ, Roth M, et al: Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord 1:256-62, 1987
18. Brenner C, Cadiou H, Vieira HL, et al: Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19:329-36, 2000
19. Busch C, Bohl J, Ohm TG: Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol Aging 18:401-6, 1997
20. Cande C, Cohen I, Daugas E, et al: Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84:215-22, 2002
21. Carter J, Lippa CF: Beta-amyloid, neuronal death and Alzheimer's disease. Curr Mol Med 1:733-7, 2001
22. Chalmers-Redman R, Elstner MQ, Mammen M, Tatton WG: Alpha-2 adrenergic receptor activation by brimonidine reduces neuronal apoptosis by inducing new protein synthesis that maintains mitochondrial pore closure. ICER Abstracts 14:257, 2001
23. Chan-Palay V, Asan E: Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol 287:373-92, 1989
24. Chan-Palay V, Asan E: Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression. J Comp Neurol 287:357-72, 1989
25. Chao HM, Osborne NN: Topically applied clonidine protects the rat retina from ischaemia/reperfusion by stimulating alpha(2)-adrenoceptors and not by an action on imidazoline receptors. Brain Res 904:126-36, 2001
26. Chen G, Goeddel DV: TNF-R1 signaling: a beautiful pathway. Science 296:1634-5, 2002
27. Chen RW, Saunders PA, Wei H, et al: Involvement of glyceraldehyde-3- phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53. J Neurosci 19:9654-62, 1999
28. Chen Z, Jia W, Kaufman PL, Cynader M: Immunohistochemical localization of dopamine-beta-hydroxylase in human and monkey eyes. Curr Eye Res 18:39-48, 1999
29. Cotman CW, Whittemore ER, Watt JA, et al: Possible role of apoptosis in Alzheimer's disease. Ann NY Acad Sci 747:36-49, 1994
30. Coull JT: Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. Drugs Aging 5:116-26, 1994
31. Cross AJ, Crow TJ, Johnson JA, et al: Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type. J Neurol Sci 64:109-17, 1984
32. Daugas E, Nochy D, Ravagnan L, et al: Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476:118-23, 2000
33. Davies DC, McCoubrie P, McDonald B, Jobst KA: Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease. Br J Ophthalmol 79:596-600, 1995
34. de la Monte SM, Sohn YK, Ganju N, Wands JR: P53- and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 78:401-11, 1998
35. de la Monte SM, Sohn YK, Wands JR: Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152:73-83, 1997
36. Deibel MR Jr, Coleman MS: Biochemical properties of purified human terminal deoxynucleotidyltransferase. J Biol Chem 255:4206-12, 1980
37. Demeester N, Baier G, Enzinger C, et al: Apoptosis induced in neuronal cells by C-terminal amyloid beta-fragments is correlated with their aggregation properties in phospholipid membranes. Mol Membr Biol 17:219-28, 2000
38. Deng Y, Lin Y, Wu X: TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16:33-45, 2002
39. Dkhissi O, Chanut E, Wasowicz M, et al: Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci 40:990-5, 1999
40. Donello JE, Padillo EU, Webster ML, et al: alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J Pharmacol Exp Ther 296:216-23, 2001
41. Dragunow M, Faull RL, Lawlor P, et al: In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6:1053-7, 1995
42. Elena PP, Kosina-Boix M, Moulin G, Lapalus P: Autoradiographic localization of beta-adrenergic receptors in rabbit eye. Invest Ophthalmol Vis Sci 28:1436-41, 1987
43. Engidawork E, Gulesserian T, Yoo BC, et al: Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 281:84-93, 2001
44. Eskes R, Desagher S, Antonsson B, Martinou JC: Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20:929-35, 2000
45. Feinstein DL, Heneka MT, Gavrilyuk V, et al: Noradrenergic regulation of inflammatory gene expression in brain. Neurochem Int 41:357-65, 2002
46. Ferrer I, Puig B, Krupinsk J, et al: Fas and Fas ligand expression in Alzheimer's disease. Acta Neuropathol (Berl) 102:121-31, 2001
47. Friedman JI, Adler DN, Davis KL: The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol Psychiatry 46:1243-52, 1999
48. Fukuhara Y, Takeshima T, Kashiwaya Y, et al: GAPDH knockdown rescues mesencephalic dopaminergic neurons from MPP+-induced apoptosis. Neuroreport 12:2049-52, 2001
49. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC: Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 61:33-44, 1995
50. German DC, White CL 3rd, Sparkman DR: Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 21:305-12, 1987
51. Gold MS, Dastmalchi S, Levine JD: Alpha 2-adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons. Pain 69:179-90, 1997
52. Golubnitschaja-Labudova O, Liu R, Decker C, et al: Altered gene expression in lymphocytes of patients with normal-tension glaucoma. Curr Eye Res 21:867-76, 2000
53. Graeber MB, Moran LB: Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts. Brain Pathol 12:385-90, 2002
54. Grosse F, Manns A: Terminal deoxyribonucleotidyl transferase (EC 2.7.7.31), in Burrell F (ed): Methods in Molecular Biology. Totowa, NJ, Humana Press, Inc., 1993, pp 95-105
55. Halestrap AP, McStay GP, Clarke SJ: The permeability transition pore complex: another view. Biochimie 84:153-66, 2002
56. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-6, 2002
57. Hedges TR 3rd, Perez Calves R, Speigelman D, et al: Retinal nerve fiber layer abnormalities in Alzheimer's disease. Acta Ophthalmol Scand 74:271-5, 1996
58. Heneka MT, Galea E, Gavriluyk V, et al: Noradrenergic de-pletion potentiates beta-amyloid-induced cortical inflammation: implications for Alzheimer's disease. J Neurosci 22:2434-42, 2002
59. Hinton DR, Sadun AA, Blanks JC, Miller CA: Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 315:485-7, 1986
60. Huang Y, Gil DW, Vanscheeuwijck P, et al: Localization of alpha 2-adrenergic receptor subtypes in the anterior segment of the human eye with selective antibodies. Invest Ophthalmol Vis Sci 36:2729-39, 1995
61. Hurvitz LM, Kaufman PL, Robin AL, et al: New developments in the drug treatment of glaucoma. Drugs 41:514-32, 1991
62. Ichimiya Y, Arai H, Kosaka K, Iizuka R: Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia. Acta Neuropathol 70:112-6, 1986
63. Ishimoto I, Kiyama H, Hamano K, et al: Co-localization of adrenergic receptors and vitamin-D-dependent calcium-binding protein (calbindin) in the dopaminergic amacrine cells of the rat retina. Neurosci Res 7:257-63, 1989
64. Ishitani R, Kimura M, Sunaga K, et al: An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J Pharmacol Exp Ther 278:447-54, 1996
65. Ishitani R, Sunaga K, Hirano A, et al: Evidence that glyceraldehyde-3- phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem 66:928-35, 1996
66. Johnson EM Jr: Possible role of neuronal apoptosis in Alzheimer's disease. Neurobiol Aging 15:8187-9, 1994
67. Justino L, Kergoat M, Bergman H, et al: Neuroretinal function is normal in early dementia of the Alzheimer type. Neurobiol Aging 22:691-5, 2001
68. Kalaria RN, Andorn AC: Adrenergic receptors in aging and Alzheimer's disease: decreased alpha 2-receptors demonstrated by [3H]p-aminoclonidine binding in prefrontal cortex. Neurobiol Aging 12:131-6, 1991
69. Kalaria RN, Andorn AC, Tabaton M, et al: Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. J Neurochem 53:1772-81, 1989
70. Kalaria RN, Stockmeier CA, Harik SI: Brain microvessels are innervated by locus ceruleus noradrenergic neurons. Neurosci Lett 97:203-8, 1989
71. Kemp JA, McKernan RM: NMDA receptor pathways as drug targets. Nat Neurosci 5(Suppl):1039-42, 2002
72. Kergoat H, Kergoat MJ, Justino L, et al: An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type. Acta Ophthalmol Scand 79:187-91, 2001
73. Kerrigan LA, Zack DJ, Quigley HA, et al: TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 115:1031-5, 1997
74. Kim HS, Lee JH, Lee JP, et al: Amyloid beta peptide induces cytochrome c release from isolated mitochondria. Neuroreport 13:1989-93, 2002
75. Kitamura Y, Shimohama S, Kamoshima W, et al: Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res 780:260-9, 1998
76. Kohler C, Orrenius S, Zhivotovsky B: Evaluation of caspase activity in apoptotic cells. J Immunol Methods 265:97-110, 2002
77. Korsmeyer SJ: BCL-2 gene family and the regulation of programmed cell death. Cancer Res 59:16938-7008, 1999
78. Korsmeyer SJ, Wei MC, Saito M, et al: Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 7:1166-73, 2000
79. Kugler S, Straten G, Kreppel F, et al: The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ 7:815-24, 2000
80. Lafarga M, Andres MA, Calle E, Berciano MT: Reactive gliosis of immature Bergmann glia and microglial cell activa-tion in response to cell death of granule cell precursors induced by methylazoxymethanol treatment in developing rat cerebellum. Anat Embryol (Berl) 198:111-22, 1998
81. Lafuente MP, Villegas-Perez MP, Sobrado-Calvo P, et al: Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 42:2074-84, 2001
82. Lassmann H, Bancher C, Breitschopf H, et al: Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89:35-41, 1995
83. Leist M, Jaattela M: Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2:589-98, 2001
84. Li BM, Kubota K: Alpha-2 adrenergic modulation of pre-frontal cortical neuronal activity related to a visual discrimination task with GO and NO-GO performances in monkeys. Neurosci Res 31:83-95, 1998
85. Li LY, Luo X, Wang X: Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95-9, 2001
86. Li WP, Chan WY, Lai HW, Yew DT: Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. J Mol Neurosci 8:75-82, 1997
87. Linner E, Popovic V, Gottfries CG, et al: The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmol Scand 79:283-5, 2001
88. Liu W, Alreja M: Norepinephrine inhibits neurons of the intermediate subnucleus of the lateral septum via alpha2-adrenoceptors. Brain Res 806:36-54, 1998
89. Liu XS, Kim CN, Yang J, et al: Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147-57, 1996
90. Loeffler M, Daugas E, Susin SA, et al: Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. Faseb J 15:758-67, 2001
91. Loffler KU, Edward DP, Tso MO: Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. Invest Ophthalmol Vis Sci 36:24-31, 1995
92. MacGibbon GA, Lawlor PA, Sirimanne ES, et al: Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res 750:223-34, 1997
93. Maier C, Steinberg GK, Sun GH, et al: Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 79:306-12, 1993
94. Mann DM, Yates PO, Marcyniuk B: A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease. J Neurol Neurosurg Psychiatry 47:201-3, 1984
95. Mann DM, Yates PO, Marcyniuk B: A comparison of nerve cell loss in cortical and subcortical structures in Alzheimer's disease. J Neurol Neurosurg Psychiatry 49:310-2, 1986
96. Mann DM, Yates PO, Marcyniuk B: Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease. Neurosci Lett 56:51-5, 1985
97. Marcyniuk B, Mann DM, Yates PO: The topography of cell loss from locus caeruleus in Alzheimer's disease. J Neurol Sci 76:335-45, 1986
98. Martinou JC, Green DR: Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2:63-7, 2001
99. Matthews KL, Chen CP, Esiri MM, et al: Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry 51:407-16, 2002
100. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, et al: Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43:1077-87, 2002
101. Mielke K, Herdegen T: JNK and p38 stress kinases-degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61:45-60, 2000
102. Migheli A, Cavalla P, Marino S, Schiffer D: A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 53:606-16, 1994
103. Milner TA, Rosin DL, Lee A, Aicher SA: Alpha2A-adrenergic receptors are primarily presynaptic heteroreceptors in the C1 area of the rat rostral ventrolateral medulla. Brain Res 821:200-11, 1999
104. Mittag TW, Danias J, Pohorenec G, et al: Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci 41:3451-9, 2000
105. Moore AH, O'Banion MK: Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease. Adv Drug Deliv Rev 54:1627-56, 2002
106. Morfini G, Pigino G, Beffert LJ, et al: Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med 2:89-99, 2002
107. Morishima-Kawashima M, Ihara Y: Alzheimer's disease: beta-Amyloid protein and tau. J Neurosci Res 70:392-401, 2002
108. Morrison JC, Nylander KB, Lauer AK, et al: Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma. Invest Ophthalmol Vis Sci 39:526-31, 1998
109. Mountjoy CQ, Bondareff W: Comparison of counts of neurons in the locus coeruleus made from serial sections and from a single section at the centre of the nucleus. Can J Neurol Sci 13:480-2, 1986
110. Mudher A, Lovestone S: Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci 25:22-6, 2002
111. Nagata S: Apoptotic DNA fragmentation. Exp Cell Res 256:12-8, 2000
112. Nagy ZS, Esiri MM: Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging 18:565-71, 1997
113. Narita M, Shimizu S, Ito T, et al: Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci LISA 95:14681-6, 1998
114. Negoescu A, Lorimier P, Labat-Moleur F, et al: In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. J Histochem Cytochem 44:959-68, 1996
115. Nesselhut T, Osborne NN: Is noradrenaline a major catecholamine in the bovine retina? Neurosci Lett 28:41-5, 1982
116. Nickells RW: Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv Ophthalmol 43(Suppl 1):S151-61, 1999
117. Nicotera P: Apoptosis and age-related disorders: role of caspase-dependent and caspase-independent pathways. Toxicol Lett 127:189-95, 2002
118. Niikura T, Hashimoto Y, Tajima H, Nishimoto I: Death and survival of neuronal cells exposed to Alzheimer's insults. J Neurosci Res 70:380-91, 2002
119. Nishimura T, Akiyama H, Yonchara S, et al: Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res 695:137-45, 1995
120. Nishizaki K, Yoshino T, Orita Y, et al: TUNEL staining of inner ear structures may reflect autolysis, not apoptosis. Hear Res 130:131-6, 1999
121. Ohm TG, Hamker LJ, Cedazo-Minguez A, et al: Apolipoprotein E and beta A4-amyloid: signals and effects. Biochem Soc Symp 67:121-9, 2001
122. Okisaka S, Murakami A, Mizukawa A, Ito J: Apoptosis in retinal ganglion cell decrease in human glaucomatous eyes. Jpn/Ophthalmol 41:84-8, 1997
123. Osborne NN: Agonist-induced stimulation of cAMP in the lens: presence of functional beta-receptors. Exp Eye Res 52:105-6, 1991
124. Osborne NN: Binding of (-)[3H]noradrenaline to bovine membrane of the retina. Evidence for the existence of alpha 2-receptors. Vision Res 22:1401-7, 1982
125. Osborne NN: Neuromediators and their receptors (adrenergic and endothelin types) in the eye. Therapie 48:549-58, 1993
126. Osborne NN: Noradrenaline, a transmitter candidate in the retina. J Neurochera 36:17-27, 1981
127. Osborne NN, Cazevieille C, Carvalho AL, et al: In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res 751:113-23, 1997
128. Osborne NN, DeSantis L, Bae JH, et al: Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp Eye Res 69:331-42, 1999
129. Osborne NN, Patel S: The presence of dopamine-beta-hydroxylase in the vertebrate retina. Neurochem Int 7:51-56, 1985
130. Parisi V, Restuccia R, Fattapposta F, et al: Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 112:1860-7, 2001
131. Parone PA, James D, Martinou JC: Mitochondria: regulating the inevitable. Biochimie 84:105-11, 2002
132. Pascual J, Grijalba B, Garcia-Sevilla JA, et al: Loss of high-affinity alpha 2-adrenoceptors in Alzheimer's disease: an autoradiographic study in frontal cortex and hippocampus. Neurosci Lett 142:36-40, 1992
133. Perry EK, Perry RH: A review of neuropathological and neurochemical correlates of Alzheimer's disease. Dan Med Bull 32(Suppl 1):27-34, 1985
134. Perry G, Cash AD, Smith MA: Alzheimer Disease and oxidative stress. J Biomed Biotechnol 2:120-3, 2002
135. Perry RT, Collins JS, Wiener H, et al: The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging 22:873-83, 2001
136. Pimplikar SW, Abeta PP: Apoptosis and Alzheimer's disease. J Alzheimers Dis 4:39-40, 2002
137. Quigley HA, Dunkelberger GR, Green WR: Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 95:357-63, 1988
138. Quigley HA, Nickells RW, Kerrigan LA, et al: Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36:774-86, 1995
139. Quigley HA, Sanchez RM, Dunkelberger GR, et al: Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci 28:913-20, 1987
140. Raina AK, Hochman A, Zhu X, et al: Abortive apoptosis in Alzheimer's disease. Acta Neuropathol (Berl) 101:305-10, 2001
141. Rank KB, Pauley AM, Bhattacharya K, et al: Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II. FEBS Lett 514:263-8, 2002
142. Rapoport M, Dawson HN, Binder LI, et al: Tau is essential to beta-amyloid-induced neurotoxidty. Proc Natl Acad Sci USA 99:6364-9, 2002
143. Reed JC, Kroemer G: Mechanisms of mitochondrial membrane permeabilization. Cell Death Differ 7:1145, 2000
144. Roucou X, Rostovtseva T, Montessuit S, et al: Bid induces cytochrome c-impermeable Bax channels in liposomes. Biochem J 363:547-52, 2002
145. Ruffolo SC, Breckenridge DG, Nguyen M, et al: BID-dependent and BID-independent pathways for BAX insertion into mitochondria. Cell Death Differ 7:1101-8, 2000
146. Sadun AA: The optic neuropathy of Alzheimer's disease. Metab Pediatr Syst Ophthalmol 12:64-8, 1989
147. Sadun AA, Bassi CJ: Optic nerve damage in Alzheimer's disease. Ophthalmology 97:9-17, 1990
148. Sambamurti K, Greig NH, Lahiri DK: Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease. Neuromolecular Med 1:1-31, 2002
149. Samejima K, Tone S, Earnshaw WC: CAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis. J Biol Chem 276:45427-32, 2001
150. Saraste A: Morphologic criteria and detection of apoptosis. Herz 24:189-95, 1999
151. Sawa A, Khan AA, Hester LD, Snyder SH: Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA 94:11669-74, 1997
152. Schneider P, Tschopp J: Apoptosis induced by death receptors. Pharm Acta Helv 74:281-6, 2000
153. Schuler M, Green DR: Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 29:684-8, 2001
154. Scorrano L, Ashiya M, Buttle K, et al: A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2:55-67, 2002
155. Seidl R, Bajo M, Bohm K, et al: Neuronal apoptosis inhibitory protein (NAIP)-like immunoreactivity in brains of adult patients with Down syndrome. J Neural Transm 57(Suppl):283-91, 1999
156. Selkoe DJ: Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc Natl Acad Sci USA 98:11039-41, 2001
157. Selznick LA, Holtzman DM, Han BH, et al: In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 58:1020-6, 1999
158. Serie JB, Steidl S, Wang RF, et al: Selective alpha 2-adrenergic agonists B-HT 920 and UK14304-18. Effects on aqueous humor dynamics in monkeys. Arch Ophthalmol 109:1158-62, 1991
159. Shimizu S, Ide T, Yanagida T, Tsujimoto Y: Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. J Biol Chem 275:12321-5, 2000
160. Shimizu S, Matsuoka Y, Shinohara Y, et al: Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol 152:237-50, 2001
161. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M: Changes in beta-adrenergic receptor subtypes in Alzheimer-type dementia. J Neurochem 48:1215-21, 1987
162. Sirover MA: New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432:159-84, 1999
163. Smale G, Nichols NR, Brady DR, et al: Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133:225-30, 1995
164. Smeets WJ, Gonzalez A: Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach. Brain Res Brain Res Rev 33:308-79, 2000
165. Smith MS, Schambra UB, Wilson KH, et al: alpha 2-Adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha 2-adrenergic receptor subtypes at four distinct levels. Brain Res Mol Brain Res 34:109-17, 1995
166. Stadelmann C, Deckwerth TL, Srinivasan A, et al: Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 155:1459-66, 1999
167. Stone LS, Broberger C, Vulchanova L, et al: Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci 18:5928-37, 1998
168. Su JH, Anderson AJ, Cummings BJ, Cotman CW: Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529-33, 1994
169. Su JH, Deng G, Cotman CW: Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 56:86-93, 1997
170. Su JH, Zhao M, Anderson AJ, et al: Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res 898:350-7, 2001
171. Susin SA, Lorenzo HK, Zamzami N, et al: Molecular characterization of mitochondrial apoptosis-inducing factor [see comments]. Nature 397:441-6, 1999
172. Tabira T, Chui DH, Kuroda S: Significance of intracellular Abeta42 accumulation in Alzheimer's disease. Front Biosci 7:a44-9, 2002
173. Tamura T, Said S, Lu W, Neufeld D: Specificity of TUNEL method depends on duration of fixation. Biotech Histochem 75:197-200, 2000
174. Tatton NA: Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol 166:29-43, 2000
175. Tatton NA, Hagl C, Nandor S, et al: Apoptotic cell death in the hippocampus due to prolonged hypothermic circulatory arrest: comparison of cyclosporine A and cycloheximide on neuron survival. Eur J Cardiothorac Surg 19:746-55, 2001
176. Tatton NA, Kish SJ: In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neurosci 77:1037-1048, 1997
177. Tatton NA, Maclean-Fraser A, Tatton WG, et al: A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann Neurol 44:8142-8, 1998
178. Tatton NA, Rideout HJ: Confocal microscopy as a tool to examine DNA fragmentation, chromatin condensation and other apoptotic changes in Parkinson's disease. Parkinsonism Rel Disord 5:179-86, 1999
179. Tatton NA, Tezel G, Insolia SA, et al: In situ detection of apoptosis in normal pressure glaucoma. A preliminary examination. Surv Ophthalmol 45(Suppl 3):S268-72; discussion S273-6, 2001
180. Tatton W, Chalmers-Redman R, Brown D, Tatton N: Apoptosis in parkinson's disease: signals for neuronal degradation. Ann Neurol (In press)
181. Tatton WG, Chalmers-Redman RM, Elstner M, et al: Glyceraldehyde-3- phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm 60(Suppl):77-100, 2000
182. Tatton WG, Chalmers-Redman RM, Tatton NA: Apoptosis and anti-apoptosis signalling in glaucomatous retinopathy. Eur J Ophthalmol 11(Suppl 2):S12-22, 2001
183. Tatton WG, Chalmers-Redman RME, Ju WJH, et al: Propargylamines induce anti-apoptotic new protein synthesis in serum and NGF withdrawn NGF-differentiated PC12 cells. J Pharmacol Exper Ther 301:753-64, 2002
184. Tezel G, Li LY, Paul RV, Wax MB: TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 42:1787-94, 2001
185. Tezel G, Wax MB: Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 20:8693-700, 2000
186. Tomlinson BE, Irving D, Blessed G: Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J Neurol Sci 49:419-28, 1981
187. Tortosa A, Lopez E, Ferrer I: Bcl-2 and Bax protein expression in Alzheimer's disease. Acta Neuropathol (Berl) 95:407-12, 1998
188. Trojanowski JQ, Lee VM: The role of tau in Alzheimer's disease. Med Clin North Am 86:615-27, 2002
189. Troy CM, Salvesen GS: Caspases on the brain. J Neurosci Res 69:145-50, 2002
190. Tsai CS, Ritch R, Schwartz B, et al: Optic nerve head and nerve fiber layer in Alzheimer's disease. Arch Ophthalmol 109:199-204, 1991
191. van Loo G, Schotte P, van Gurp M, et al: Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ 8:1136-42, 2001
192. Vickers JC: The cellular mechanism underlying neuronal degeneration in glaucoma: parallels with Alzheimer's disease. Aust N Z J Ophthalmol 25:105-9, 1997
193. Vidal-Sanz M, Lafuente MP, Mayor S, et al: Retinal ganglion cell death induced by retinal ischemia. Neuroprotective effects of two alpha-2 agonists. Surv Ophthalmol 45(Suppl 3):S261-7; discussion S273-6, 2001
194. Vidal-Sanz M, Lafuente MP, Mayor-Torroglosa S, et al: Brimonidine's neuroprotective effects against transient ischaemia- induced retinal ganglion cell death. Eur J Ophthalmol 11(Suppl 2):S36-40, 2001
195. Vidovic M, Cohen D, Hill CE: Identification of alpha 2 adrenergic receptor gene expression in sympathetic neurones using polymerase chain reaction and in situ hybridization. Brain Res Mol Brain Res 22:49-56, 1994
196. Vieira HL, Haouzi D, El Hamel C, et al: Permeabilization of the
197. Wadia JS, Chalmers-Redman RME, Ju WJH, et al: Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl. J Neurosci 18:932-47, 1998
198. Wajant H: The Fas signaling pathway: more than a paradigm. Science 296:1635-6, 2002
199. Wanaka A, Kiyama H, Murakami T, et al: Immunocytochemical localization of beta-adrenergic receptors in the rat brain. Brain Res 485:125-40, 1989
200. Waring P, Mullbacher A: Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol 77:312-7, 1999
201. Weber AJ, Chen H, Hubbard WC, Kaufman PL: Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Invest Ophthalmol Vis Sci 41:1370-9, 2000
202. Wei MC, Zong WX, Cheng EH, et al: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-30, 2001
203. Wheeler LA, Gil DW, WoldeMussie E: Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Surv Ophthalmol 45(Suppl 3):S290-4; discussion S295-6, 2001
204. Wheeler LA, Tatton NA, Elstner MQ, et al: Alpha 2 adrenergic receptor activation by brimonidine reduces neuronal apoptosis through Akt protein kinase B dependent new synthesis of BCL-2. ARVO Abstracts 49:2216, 2001
205. Wheeler LA, Woldemussie E: Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma. Eur J Ophthalmol 11(Suppl 2):S30-5, 2001
206. Winblad B, Hardy J, Backman L, Nilsson LG: Memory function and brain biochemistry in normal aging and in senile dementia. Ann NY Acad Sci 444:255-68, 1985
207. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA: Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 42:2849-55, 2001
208. Wood JP, DeSantis L, Chao HM, Osborne NN: Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA. Exp Eye Res 72:79-86, 2001
209. Xiang H, Kinoshita Y, Knudson CM, et al: Bax involvement in p53-mediated neuronal cell death. J Neurosci 18:1363-73, 1998
210. Yin KJ, Lee JM, Chen SD, et al: Amyloid-beta induces Smac release via AP-1/Bim activation in cerebral endothelial cells. J Neurosci 22:9764-70, 2002
211. Yoles E, Wheeler LA, Schwartz M: Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 40:65-73, 1999
212. Yuan L, Neufeld AH: Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32:42-50, 2000
213. Yucel YH, Zhang Q, Gupta N, et al: Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 118:378-84, 2000
214. Yucel YH, Zhang Q, Weinreb RN, et al: Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci 42:3216-22, 2001
215. Zamzami N, El Hamel C, Maisse C, et al: Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene 19:6342-50, 2000
216. Zou H, Henzel WJ, Liu XS, et al: Apaf-1, a human protein homologous to C-elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-13, 1997